Skip to content

On this page

Lartruvo

olaratumab

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Lartruvo

Proper name

olaratumab

Licence type

351(a)

BLA number

761038

Applicant

Eli Lilly and Company

Center

CDER

Presentations

2

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
190MG/19ML (10MG/ML)	Injection	Intravenous	Single-Dose Vial	Disc	July 10, 2017
500MG/50ML (10MG/ML)	Injection	Intravenous	Single-Dose Vial	Disc	October 19, 2016

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	February 25, 2020

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity